[1] 袁晓兰,李丽美,和秀魁,等. 全面放开“二孩”政策前后广东省妇幼保健院住院孕产妇分娩情况分析[J]. 中国妇幼保健,2018,33(2):241-243.
[2] Thorpe PG, Gilboa SM, Hernandez-Diaz S, et al.Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk[J]. Pharmacoepidemiol Drug Saf, 2013, 22(9): 1013-1018.
[3] 王然,冯欣,杜博冉. 围孕期妊娠用药暴露风险评价与药学实践进展[J]. 中国药物警戒,2023,20(7):836-840.
[4] Munsie JW, Lin S, Browne ML, et al.Maternal bronchodilator use and the risk of orofacial clefts[J]. Hum Reprod, 2011, 26(11): 3147-3154.
[5] Olesen C, Thrane N, Nielsen GL, et al.A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes[J]. Respiration, 2001, 68(3): 256-261.
[6] 李丽莎,尹佳. 妊娠期哮喘用药的安全性[J]. 中华临床免疫和变态反应杂志,2017,11(2):184-191.
[7] Jones AJ, Mathad JS, Dooley KE, et al.Evidence for implementation: management of TB in HIV and pregnancy[J]. Curr HIV/AIDS Rep, 2022, 19(6): 455-470.
[8] 高微微. 特殊人群结核病治疗[M]. 北京:科学出版社, 2011.
[9] Zhang HY, Liu J, Liu TH, et al.Antenatal maternal medication administration in preventing respiratory distress syndrome of premature infants: a network meta-analysis[J]. Clin Respir J, 2018, 12(10): 2480-2490.
[10] 特殊人群普通感冒规范用药专家组. 特殊人群普通感冒规范用药的专家共识[J]. 国际呼吸杂志,2015,35(1):1-5.
[11] Giamarellou H, Kolokythas E, Petrikkos G, et al.Pharmacokinetics of three newer quinolones in pregnant and lactating women[J]. Am J Med, 1989, 87(5A): 49S-51S.
[12] Polachek H, Debotton N, Feinshtein V, et al.The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts[J]. Drug Des Devel Ther, 2018, 12: 4129-4138.
[13] Bar-Oz B, Moretti ME, Boskovic R, et al.The safety of quinolones—a meta-analysis of pregnancy outcomes[J]. Eur J Obstet Gynecol Reprod Biol, 2009, 143(2): 75-78.
[14] Padberg S, Wacker E, Meister R, et al.Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones[J]. Antimicrob Agents Chemother, 2014, 58(8): 4392-4398.
[15] Ziv A, Masarwa R, Perlman A, et al.Pregnancy outcomes following exposure to quinolone antibiotics -- a systematic-review and meta-analysis[J]. Pharm Res, 2018, 35(5): 109.
[16] 王然,李轶凡,刘小艳,等. 1 例妊娠期药物暴露风险的药学监护[J]. 中国药物警戒,2023,20(8):933-934,960.
[17] 袁敏,张斌. 孕早期误用喹诺酮类药物的妊娠结局及相关机制研究进展[J]. 中国临床药学杂志,2021,30(2):157-160.
[18] 韩朝宏,冯欣,唐红波,等. 550 例妊娠期妇女用药情况调查分析[J]. 中国药物警戒,2012,9(9):558-559.
[19] Tang L, Lee AH, Binns CW, et al.Consumption of Chinese herbal medicines during pregnancy and postpartum: a prospective cohort study in China[J]. Midwifery, 2016, 34: 205-210.
[20] 沈晓妍,谢小芳,沈浩,等. 妊娠期中药应用安全性评价的思路与策略[J]. 医药导报,2023,42(6):858-862.
[21] 王宇光,金锐,孔祥文,等. 中药妊娠期用药的安全性等级研究[J]. 中国中药杂志,2016,41(1):150-153.
[22] 杨海卿,王科峰. 妊娠期中药安全性研究及合理应用探讨[J]. 临床合理用药杂志,2012,5(5):176-177.
[23] 郑依玲,梅全喜,戴卫波,等. 妊娠禁忌中药研究概述[J]. 中国药房,2018,29(3):421-424.
[24] 肖泓,肖庆慈. 地龙对妊娠影响之初探[J]. 云南中医中药杂志,2000,21(3):2.